Arrhythmogenic cardiomyopathy (ACM) is an arrhythmogenic disorder of the myocardium. ACM incorporates a broad spectrum of genetic, systemic, infectious, and inflammatory disorders.
The ACM phenotype overlaps with other cardiomyopathies, particularly dilated cardiomyopathy with arrhythmia presentation that may be associated with ventricular dilatation and/or impaired systolic function. The webinar presenters will review Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy 2019 consensus statement, recommendations of the expert writing group, and provide clinicians with guidance on evaluation and management of ACM, including clinically relevant information on genetics.